Profund Advisors LLC lowered its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 12.2% during the fourth quarter, HoldingsChannel reports. The firm owned 19,799 shares of the medical instruments supplier’s stock after selling 2,755 shares during the quarter. Profund Advisors LLC’s holdings in DENTSPLY SIRONA were worth $1,303,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of the business. BlackRock Inc. raised its position in DENTSPLY SIRONA by 0.7% in the 4th quarter. BlackRock Inc. now owns 14,169,813 shares of the medical instruments supplier’s stock valued at $932,797,000 after purchasing an additional 104,894 shares in the last quarter. Ruane Cunniff & Goldfarb Inc. raised its position in DENTSPLY SIRONA by 0.5% in the 3rd quarter. Ruane Cunniff & Goldfarb Inc. now owns 8,890,655 shares of the medical instruments supplier’s stock valued at $531,750,000 after purchasing an additional 40,767 shares in the last quarter. Jackson Square Partners LLC raised its position in DENTSPLY SIRONA by 8.8% in the 4th quarter. Jackson Square Partners LLC now owns 6,891,530 shares of the medical instruments supplier’s stock valued at $453,669,000 after purchasing an additional 556,624 shares in the last quarter. Neuberger Berman Group LLC raised its position in DENTSPLY SIRONA by 5.3% in the 3rd quarter. Neuberger Berman Group LLC now owns 5,781,470 shares of the medical instruments supplier’s stock valued at $345,790,000 after purchasing an additional 292,505 shares in the last quarter. Finally, Atlanta Capital Management Co. L L C raised its position in DENTSPLY SIRONA by 0.6% in the 3rd quarter. Atlanta Capital Management Co. L L C now owns 5,464,104 shares of the medical instruments supplier’s stock valued at $326,808,000 after purchasing an additional 33,162 shares in the last quarter. 96.80% of the stock is currently owned by institutional investors.
A number of research firms have issued reports on XRAY. HC Wainwright set a $63.00 price target on DENTSPLY SIRONA and gave the company a “hold” rating in a research report on Monday, March 5th. Barclays began coverage on DENTSPLY SIRONA in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $62.00 price target on the stock. Barrington Research reaffirmed an “outperform” rating and issued a $70.00 price target (down previously from $73.00) on shares of DENTSPLY SIRONA in a research report on Monday, March 5th. BidaskClub lowered DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, February 28th. Finally, JPMorgan Chase & Co. reduced their price target on DENTSPLY SIRONA from $75.00 to $70.00 and set an “overweight” rating on the stock in a research report on Monday, March 5th. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $67.43.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.01. DENTSPLY SIRONA had a positive return on equity of 8.35% and a negative net margin of 39.39%. The business had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter last year, the company earned $0.67 EPS. The business’s quarterly revenue was up 9.5% on a year-over-year basis. research analysts forecast that DENTSPLY SIRONA Inc will post 2.74 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Thursday, March 29th will be given a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a dividend yield of 0.60%. The ex-dividend date is Wednesday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -5.09%.
In other news, Director Eric Brandt sold 6,409 shares of the firm’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $68.04, for a total transaction of $436,068.36. Following the sale, the director now owns 12,073 shares of the company’s stock, valued at approximately $821,446.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.99% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Profund Advisors LLC Has $1.30 Million Holdings in DENTSPLY SIRONA Inc (XRAY)” was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3259494/profund-advisors-llc-has-1-30-million-holdings-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.